E-Folder
#1 in Business Subscribe Email Print

You are here: Home > Business > Team Building > Chasing Chickens Builds a Better Culture

Tags

  • products
  • distributor
  • capture
  • companies involved
  • technology company
  • companies involved

  • Links

  • The Keys To A Great Online Profile
  • Profit From Reading
  • Steganography in Principle
  • E-Folder - Chasing Chickens Builds a Better Culture

    A technology company and major distributor teamed up as business partner
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    s to serve the banking market.

    But both companies were so proud of thei
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    own capabilities and relationships they ended up working around each ot
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    er rather than with each other to secure new business.

    The head of the
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    distributor finally called his counterpart at the technology company and
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    said, ‘I’d rather see our people compete by chasing chickens than get in
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    each other’s way chasing the same customers!’

    To his surprise, his coun
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    terpart declared, ‘You’re on. Let’s do it!’

    Two weeks later the sales f
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    rces of both companies met on a large open field. One hundred chickens w
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    re released and the race to capture ‘chicken-share’ was on!

    Net results
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    Technology Company – 33 chickens. Major Distributor – 32 chickens. The
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    other 35 chickens escaped.

    Everyone got the message. After this excepti
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    nal event, both sides worked more closely to capture the total market.

    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ey Learning Point
    ------------------------------------------------
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    --------------------------------
    Building a culture of partnership
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    akes more than just business agreements. You need to cultivate a spirit
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    hat brings people together.

    Action Steps
    ------------------------
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    --------------------------------------------------------
    What memor
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ble activities of culture-building have you participated in lately? Whic
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    do you recall? What episodes of bonding and camaraderie will you create


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-folder.org.ua/article/45570/e-folder-Chasing-Chickens-Builds-a-Better-Culture.html">Chasing Chickens Builds a Better Culture</a>

    BB link (for phorums):
    [url=http://www.e-folder.org.ua/article/45570/e-folder-Chasing-Chickens-Builds-a-Better-Culture.html]Chasing Chickens Builds a Better Culture[/url]

    Related Articles:

    Finding a Lawyer

    What Does Accounting Have to Do With Process Improvements?

    Top 10 Article Writing and Submission Mistakes That Stop Sales

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com